Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp

  • Founded in 2009
  • 501-1000 Employees
  • $125M Post-IPO Debt on 2022-09

Careers at Adaptive Biotechnologies Corp


About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp. is a leader in immune-driven medicine, aiming to revolutionize disease detection and treatment. By utilizing the adaptive immune system, the company develops diagnostic and therapeutic solutions powered by its innovative Immune Medicine platform. They offer clinical diagnostics, particularly in Minimal Residual Disease (MRD) testing, and engage in drug discovery and therapeutic development through adaptive immunosequencing technologies. Their biopharma services support the progression of clinical trials and the development of transformative medicines. Adaptive Biotechnologies leverages the complex biology of the immune system, decoding it to advance medical science and improve patient outcomes.